The company said in late January that the vaccine was 66 percent effective in a global study, with efficacy ranging as high as 72 percent in the U.S.
Related posts:
G-7 nations call for thorough probe of Covid origins in China
Obamacare now appears safe. The battle over its future continues.
FDA chief calls for probe of relationship between agency and Biogen
Vaccines will get full FDA approval, Fauci predicts
Top U.S. officials see booster shots as inevitable
Social media must do more to support vaccination, surgeon general says
China says it is ‘shocked’ by WHO plan for Covid origins study
Divided Supreme Court considers who can defend abortion restrictions
FDA authorizes Moderna, J&J Covid-19 boosters, allows mix-and-match shots
U.S. to defer 33M Covid vaccine doses to Africa
Pfizer asks FDA to authorize Covid shot for children under 5
Congressional resistance puts future Covid funds in jeopardy
